These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 28160250)

  • 1. Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.
    Mantzaris GJ
    Curr Treat Options Gastroenterol; 2017 Mar; 15(1):84-104. PubMed ID: 28160250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
    Gómez-García M; Cabello-Tapia MJ; Sánchez-Capilla AD; De Teresa-Galván J; Redondo-Cerezo E
    World J Gastroenterol; 2013 Aug; 19(30):4877-86. PubMed ID: 23946592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study.
    Gensmyr-Singer H; Werner M; Karling P
    Therap Adv Gastroenterol; 2024; 17():17562848241228064. PubMed ID: 38384282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
    Teml A; Schaeffeler E; Herrlinger KR; Klotz U; Schwab M
    Clin Pharmacokinet; 2007; 46(3):187-208. PubMed ID: 17328579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.
    Bermejo F; Aguas M; Chaparro M; Domènech E; Echarri A; García-Planella E; Guerra I; Gisbert JP; López-Sanromán A;
    Gastroenterol Hepatol; 2018 Mar; 41(3):205-221. PubMed ID: 29357999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource.
    Stournaras E; Qian W; Pappas A; Hong YY; Shawky R; ; Raine T; Parkes M;
    Gut; 2021 Apr; 70(4):677-686. PubMed ID: 33004550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for thioguanine therapy in IBD in 2017 and beyond?
    Taylor KM; Ward MG; Blaker PA; Sparrow MP
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):473-486. PubMed ID: 28276819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
    Brookes MJ; Green JR
    Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How important is onset of action in ulcerative colitis therapy?
    Masson S; Nylander D; Mansfield JC
    Drugs; 2005; 65(15):2069-83. PubMed ID: 16225364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn's disease and ulcerative colitis.
    Hashash JG; Fadel CGA; Rimmani HH; Sharara AI
    Ann Gastroenterol; 2021; 34(5):612-624. PubMed ID: 34475731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.
    Boyle BM; Kappelman MD; Colletti RB; Baldassano RN; Milov DE; Crandall WV
    World J Gastroenterol; 2014 Jul; 20(27):9185-90. PubMed ID: 25083093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
    Axelrad JE; Roy A; Lawlor G; Korelitz B; Lichtiger S
    World J Gastroenterol; 2016 Dec; 22(46):10103-10117. PubMed ID: 28028358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease.
    Ranjan MK; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Golla R; Sharma R; Sahni P; Das P; Makharia G; Kedia S; Ahuja V
    Int J Colorectal Dis; 2022 Aug; 37(8):1817-1826. PubMed ID: 35835862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM; Lijftogt T; Kindermann A; Damen G; de Ridder L; Escher JC; Mearin ML; de Meij T; Hendriks D; George E; Hummel T; Norbruis O; van Rheenen P
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
    J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.